Navigation Links
Dr. Philip A. DeFina of International Brain Research Foundation Joins Montgomery Academy Board of Trustees
Date:6/11/2009

Chester Township scientist, author and lecturer lends his expertise to special ed school

MENDHAM TOWNSHIP, N.J., June 11 /PRNewswire-USNewswire/ -- Montgomery Academy's Board of Trustees voted unanimously during its May meeting to name Dr. Philip A. DeFina to the Board of the nonprofit, state approved school.

Dr. DeFina founded the nonprofit International Brain Research Foundation and serves as both its Chief Executive Officer and Chief Scientific Officer. He has been a Guest Researcher at the National Institute of Health and a member of the International Neuroscience Subcommittee of the World Health Organization. A pioneer in developing and directing clinical training programs in the cognitive neurosciences, Dr. DeFina has worked to develop groundbreaking treatments for traumatic brain injury, coma, Alzheimer's, autism and Parkinson's. DeFina, himself an Army veteran, has revived over forty patients from minimally conscious or vegetative states including five injured U.S. soldiers. He has worked in collaboration with the Department of Defense and is the chief consultant for the traumatic brain injury program at Kessler Institute for Rehabilitation. His treatment protocols include electronic brain stimulation and hyperbaric oxygen induction, among other therapies, to help balance the electrical and chemical activity in the brain.

"It is a great honor to have Phil join Montgomery Academy's Board," said J. Anthony Manger of Norris, McLaughlin & Marcus, P.A., who chairs the Board of Trustees and also serves as an officer of its Foundation. "Phil's powerful and cutting edge work in neuroscience and brain health makes him particularly well suited to guide this gem of a school as it enters its 40th year of service to classified and autistic students. We are absolutely thrilled that he's accepted our invitation to join the Board and look forward to partnering with him to promote his vitally important brain research. Phil has written texts on educational neuropsychology and assessment and specializes in learning disabilities, psychiatric and autism spectrum disorders which affect Montgomery Academy students and many youngsters in our state."

Montgomery Academy delivers individualized instruction, counseling, transition, performing arts, athletics, technology, social skills and summer programs to students from over fifty sending districts in eight New Jersey counties. Its mission is to support and nurture youngsters who have emotional, behavioral and learning challenges that have not been met in conventional public school settings. It's a place where students can truly be themselves -- guided toward self-confidence, self-governance and self-knowledge in a reassuring atmosphere of trust and mutual respect. Making choices, cultivating interests: these are at the heart of the Montgomery Academy experience. To learn more about how Montgomery Academy creates opportunity for students with disabilities, please visit www.montgomeryacademyonline.org or call the school at 908.234.2840.


'/>"/>
SOURCE Montgomery Academy Foundation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. First Circuit Court of Appeals Rules Against Philip Morris in Lights Class Action
2. MEDRAD Announces eCoil(TM) for Siemens, Philips 3.0T MR Scanners
3. Audio from Medialink and Philips: Americas Dirty Mouths
4. Neurochem announces departure of Dr. Philippe Calais, President, Global Business
5. AUDIO from Medialink and Philips: Getting Rid of the Uninvited Holiday Guests on Your Toothbrush
6. North Carolina Coalition on Donation Selects Corder Philips for Newest Campaign
7. Royal Philips Electronics to Acquire Respironics for USD $66.00 Per Share
8. Philip Morris International Spin-off Should Spur Nations to Take Urgent Action to Reduce Tobacco Use
9. Philip Coelho Joins Mediware Board
10. VIDEO from Medialink and Philips: Philips Electronics Unveils First Imagination Light Canvas at the New Mercy Medical Center in Rogers AR
11. Philips Supports the Boston Marathon as the Sole Provider of Life-Saving Medical Devices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal their media with ... X," said Christina Austin - CEO of Pixel Film Studios. , ProSlice Color ... users can now reveal the media of their split screens with growing colorful ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... patient payment industry today announced its strategic partnership with Connance, a healthcare ... , The two companies’ proven, proprietary technology combine to provide health systems, ...
(Date:6/27/2016)... Park, KS (PRWEB) , ... June 27, 2016 , ... ... in retailers of Eyeglasses . , Millions of individuals in the United States ... eyeglasses have become a way to both correct vision and make a fashion statement. ...
(Date:6/26/2016)... Battle Creek, Michigan (PRWEB) , ... June 26, 2016 , ... ... abuse, joined as sponsor of the 2016 Cereal Festival and World’s Longest Breakfast Table ... held in honor of the city’s history as home to some of the world’s ...
(Date:6/26/2016)... ... ... PawPaws brand pet supplements owned by Whole Health Supply is ... of felines. The formula is all-natural and is made from Chinese herbs that have ... Kidney Support Supplement Soft Chews are Astragalus Root Extract and Rehmannia Root Extract ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 ... appointment of Dr. Edward Futcher to ... Director, effective June 23, 2016.Dr. Futcher was also ... and Governance Committees.  As a non-executive member of ... expertise and strategic counsel to VolitionRx in connection ...
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... 52" report to their offering. ... creates a favourable commercial environment for MedImmune to enter. The ... that will serve to drive considerable growth for effective anti-influenza ... to cap sales considerably, but development is still in its ...
Breaking Medicine Technology: